Vaginal dryness in menopause

Changes can affect more than dryness

Genitourinary syndrome of menopause (GSM) is the name for vaginal, vulvar, and urinary changes related to declining estrogen around menopause. Symptoms may include:

• vaginal or vulvar dryness, burning, irritation, or itching;
• pain with penetration or soreness afterward;
• light bleeding with sex from fragile tissue;
• urinary urgency, frequency, burning, or recurrent urinary tract infections; and
• reduced sexual comfort or desire because sex has become painful.

GSM tends not to follow the same timeline as hot flashes. Without treatment, vaginal and urinary symptoms may persist or worsen after menopause.

Compare relief options

More columns are available. Swipe left to see them.

Systemic hormone therapy can also improve GSM when it is already being used for hot flashes, but local therapy is usually the more direct conversation when vaginal or urinary symptoms are the only concern.

How to choose a lubricant or moisturizer

Look for on the label

• For sex now: a lubricant; water- and silicone-based products are compatible with latex condoms.
• For day-to-day dryness: a product specifically labeled as a vaginal moisturizer, with a regular-use schedule.
• For device use: compatibility instructions before combining a silicone-based lubricant with a silicone device.

Avoid or stop

• fragranced, warming, cooling, or flavored products when tissue is sensitive;
• household oils or lotions that may irritate tissue or damage barrier contraception; and
• any product that increases burning or irritation.

If sex hurts, do not push through pain. More arousal time, a different position, nonpenetrative intimacy, dilators when clinically appropriate, or pelvic-floor therapy may help depending on the cause.

If practical measures are not enough, ask your clinician which local or systemic option matches your symptoms and health history.

When symptoms may be something else

Vaginal or urinary infection, sexually transmitted infection, vulvar skin disease, allergic or irritant reaction, pelvic-floor pain, endometriosis, and other gynecologic conditions can overlap with GSM.

Arrange assessment for bleeding after menopause, persistent bleeding with sex, unusual discharge or odor, sores, a vulvar color or skin change, severe pelvic pain, fever, or urinary symptoms that recur or include blood. Burning with urination may be GSM, a UTI, or both; a urine test can change treatment.

A breast-cancer history needs a coordinated decision

For people with a history of estrogen-dependent breast cancer, nonhormone measures are generally tried first. When symptoms remain severe, ACOG states that low-dose vaginal estrogen may be considered after discussion of risks and benefits; people taking aromatase inhibitors should make that decision with their gynecologist and oncologist.

ACOG notes that vaginal DHEA or testosterone may help when vaginal estrogen is not an option, but the current Intrarosa (prasterone) label warns about use in people with current or past breast cancer because estrogen is a metabolite and the product was not studied in that population. ACOG also says ospemifene may be considered for some people with a history of estrogen-dependent breast cancer, while noting limited long-term safety data; the current Osphena label contraindicates an estrogen-dependent cancer or tumor and warns about known, suspected, or past breast cancer.

Those differences make this a coordinated gynecology-oncology decision, not a blanket “safe” or “never” rule. Bring the exact proposed product to the discussion.

Prepare for an appointment

Bring:

• where discomfort occurs and whether it is dryness, burning, itching, or pain;
• timing with sex, urination, products, periods, or cancer treatment;
• bleeding, discharge, odor, sores, or urinary infections;
• every lubricant, moisturizer, prescription, and supplement tried;
• uterus and ovary status; and
• personal cancer, clot, liver, and cardiovascular history.

Ask: “Does this look like GSM alone, do I need testing for another cause, and which local or nonhormone option best matches my main symptom?”

Use the broad menopause treatment comparison if hot flashes, sleep, or mood also need attention. Review systemic versus local hormone therapy before assuming all estrogen products have the same exposure or purpose.

The vaginal dryness in menopause quiz can help organize symptoms, treatments tried, and warning signs before an appointment. It cannot diagnose GSM or another cause.